Download FREE Report Sample
Download Free sampleMetformin, marketed under the trade name?Glucophage?among others, is the?first-line?medication for the treatment of?type 2 diabetes, particularly in people who are?overweight.
Metformin Hydrochloride Tablet Market contains market size and forecasts of Metformin Hydrochloride Tablet in global, including the following market information:
Global Metformin Hydrochloride Tablet Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Metformin Hydrochloride Tablet Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Metformin Hydrochloride Tablet companies in 2021 (%)
The global Metformin Hydrochloride Tablet market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
50 Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Metformin Hydrochloride Tablet include Novartis, Apotex, Mylan, Mallinckrodt, Teva Pharmaceuticals, Alkem, Dr. Reddy?s Laboratories, Atlas Pharmaceuticals and Sun Pharmaceutical Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
surveyed the Metformin Hydrochloride Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metformin Hydrochloride Tablet Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Metformin Hydrochloride Tablet Market Segment Percentages, by Type, 2021 (%)
50 Tablets
100 Tablets
Other
Global Metformin Hydrochloride Tablet Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Metformin Hydrochloride Tablet Market Segment Percentages, by Application, 2021 (%)
Hospital
Drugs Stores
Global Metformin Hydrochloride Tablet Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Metformin Hydrochloride Tablet Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metformin Hydrochloride Tablet revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Metformin Hydrochloride Tablet revenues share in global market, 2021 (%)
Key companies Metformin Hydrochloride Tablet sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Metformin Hydrochloride Tablet sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Apotex
Mylan
Mallinckrodt
Teva Pharmaceuticals
Alkem
Dr. Reddy?s Laboratories
Atlas Pharmaceuticals
Sun Pharmaceutical Industries
Torrent Pharmaceuticals
Bristol-Myers Squibb
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
